search
Back to results

High Versus Low Target Mean Arterial Pressure in Septic Shock in Critically Ill Cirrhotics

Primary Purpose

Cirrhosis

Status
Completed
Phase
Not Applicable
Locations
India
Study Type
Interventional
Intervention
High Target Mean Arterial Pressure
Low Target Mean Arterial Pressure
Sponsored by
Institute of Liver and Biliary Sciences, India
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Cirrhosis

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Critically ill cirrhotics with septic shock

Exclusion Criteria:

  • Patients with age less than 18 years
  • Severe known cardiopulmonary disease (structural or valvular heart disease, coronary artery disease, COPD)
  • Pregnancy
  • Chronic kidney disease on hemodialysis
  • Extremely moribund patients with an expected life expectancy of less than 24 hours
  • Failure to give informed consent from family members.
  • Hemodynamic instability requiring very high dose of vasopressors

Sites / Locations

  • Institute of Liver and Biliary Sciences

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

High Target Mean Arterial Pressure

Low target Mean Arterial Pressure

Arm Description

Outcomes

Primary Outcome Measures

Survival in both groups

Secondary Outcome Measures

Duration of mechanical ventilation
Incidence of intradialytic hypotension in patients undergoing Renal Replacement Therapy
Duration of Intensive Care Unit /Hospital stay
Reversal of shock in both groups
Acute Kidney Injury in both groups.

Full Information

First Posted
April 10, 2017
Last Updated
September 20, 2022
Sponsor
Institute of Liver and Biliary Sciences, India
search

1. Study Identification

Unique Protocol Identification Number
NCT03145168
Brief Title
High Versus Low Target Mean Arterial Pressure in Septic Shock in Critically Ill Cirrhotics
Official Title
High Versus Low Target Mean Arterial Pressure in Septic Shock in Critically Ill Cirrhotics -A Randomized Controlled Trial
Study Type
Interventional

2. Study Status

Record Verification Date
September 2022
Overall Recruitment Status
Completed
Study Start Date
September 19, 2018 (Actual)
Primary Completion Date
March 18, 2021 (Actual)
Study Completion Date
March 18, 2021 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Institute of Liver and Biliary Sciences, India

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Study Design: A randomized controlled study. The study will be conducted on patients admitted to Department of Hepatology from April 2017 to October 2017 at ILBS, New Delhi Study group will comprise of patients critically ill cirrhotics with septic shock All included patients would be randomised to low target MAP group (60-65mm Hg) or high target group (80-85 mm of Hg). Patients older than 18 years of age will be enrolled if they have septic shock that is refractory to fluid resuscitation and if they required vasopressors (norepinephrine or epinephrine or terlipressin) at a minimum infusion rate of 0.1 μg per kilogram per minute. Standard criteria will be considered to define refractoriness to fluids. The target MAP would be maintained for a max. of 5 days or until recovery or shock and or AKI. In the high-target group, a reduction in vasopressor doses to maintain a mean arterial pressure of 65 to 70 mm Hg will be done in case of any of the prespecified serious adverse events that could potentially be related to an increased rate of vasopressor infusion occurred. These events could be: clinically relevant bleeding (i.e., transfusion requirements of at least 2 units of packed red cells), myocardial infarction (defined as typical electrocardiographic changes, with a concomitant increase in troponin, and segmental echocardiographic hypokinesia or akinesia, with the infarction confirmed, when possible, by means of coronary angiography), major ventricular arrhythmia, poorly tolerated supraventricular arrhythmia, mesenteric ischemia, and distal-limb ischemia. • Septic shock would be defined as clinical construct of sepsis with persisting hypotension requiring vasopressors to maintain MAP>=65 mm of Hg and having a serum lactate >2 mmol/L despite adequate volume resuscitation

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cirrhosis

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
150 (Actual)

8. Arms, Groups, and Interventions

Arm Title
High Target Mean Arterial Pressure
Arm Type
Experimental
Arm Title
Low target Mean Arterial Pressure
Arm Type
Active Comparator
Intervention Type
Other
Intervention Name(s)
High Target Mean Arterial Pressure
Intervention Description
High target group (80-85 mm of Hg).
Intervention Type
Other
Intervention Name(s)
Low Target Mean Arterial Pressure
Intervention Description
Low target MAP group (60-65mm Hg).
Primary Outcome Measure Information:
Title
Survival in both groups
Time Frame
28 days
Secondary Outcome Measure Information:
Title
Duration of mechanical ventilation
Time Frame
3 months
Title
Incidence of intradialytic hypotension in patients undergoing Renal Replacement Therapy
Time Frame
3 months
Title
Duration of Intensive Care Unit /Hospital stay
Time Frame
3 months
Title
Reversal of shock in both groups
Time Frame
Day 5
Title
Acute Kidney Injury in both groups.
Time Frame
Day 5

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Critically ill cirrhotics with septic shock Exclusion Criteria: Patients with age less than 18 years Severe known cardiopulmonary disease (structural or valvular heart disease, coronary artery disease, COPD) Pregnancy Chronic kidney disease on hemodialysis Extremely moribund patients with an expected life expectancy of less than 24 hours Failure to give informed consent from family members. Hemodynamic instability requiring very high dose of vasopressors
Facility Information:
Facility Name
Institute of Liver and Biliary Sciences
City
New Delhi
State/Province
Delhi
ZIP/Postal Code
110070
Country
India

12. IPD Sharing Statement

Plan to Share IPD
Undecided

Learn more about this trial

High Versus Low Target Mean Arterial Pressure in Septic Shock in Critically Ill Cirrhotics

We'll reach out to this number within 24 hrs